top of page

Chronic Hepatitis B Treatment

The Gastroenterology Institute is the leading Gastroenterology center in Cuba with an emphasis on research. It stands out in the training of professionals dedicated to the specialty, considering Pediatric Gastroenterology with invaluable development.

​

Chronic Hepatitis B Virus Treatment (HeberNasvac® Vaccine)

​

It allows for the comprehensive evaluation of adult and pediatric patients with chronic Hepatitis B Virus, from prevention with prophylactic vaccination, oral antivirals (Tenofovir) and immunomodulators, in addition to therapeutic vaccination (HeberNasvac), to diagnosis and treatment with treatments produced in Cuba. HeberNasvac® is administered via mucosal (intranasal) and parenteral (subcutaneous) routes. HeberNasvac® causes a strong immune response.

​

Patients not approved for the program:

  • More than 6 months disease positive adult patients.

  • Patients with hepatic enzymes values less than 500 UI/L

  • Patients with liver cirrhosis.

  • Patients with liver cancer.

  • Patients with liver transplants.

  • Patients with acute illness.

  • Patients with liver failure.Patients with immunodeficiency or those taking steroid medications for a long time are not treated.

Vaccine

Registration is easy.  Follow the steps and we will get in touch with you shortly to advise you further.

bottom of page